Browsing: YmAbs

Analysis

Y-mAbs: They Have Earnings, But Still Seek The Big Hit

October 14, 2023

anamejia18/iStock via Getty Images Topline Summary Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) is a commercial-stage biotech company producing antibody-based therapies for the…

We Asked New Yorkers if They’d Heard of Sam Bankman-Fried

October 1, 2023

FTX and Alameda Move Nearly $20,000,000 in Solana (SOL) and Other Altcoins in Just One Day: On-Chain Data

October 30, 2023

Mixin Network Announces $20 Mln Bug Bounty For Return Of Stolen Assets

September 29, 2023

Type above and press Enter to search. Press Esc to cancel.